NCT01054703

Clinical Evaluation of the Ethmoid Sinus Spacer

Clinical Evaluation of the Safety and Feasibility of the Ethmoid Sinus Spacer and Access System With Drug (SPACER)

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Integra LifeSciences Corporation · Industry
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

Evaluation of treatment of the ethmoid sinuses with the Ethmoid Sinus Spacer and Access system

Conditions

• Sinusitis, Chronic Rhinosinusitis

Interventions

Type	Name	Description
DEVICE	Ethmoid Sinus Spacer	Ethmoid Sinus Spacer and Access System used for the local delivery of Kenalog-40

Timeline

• Start date: 2007-04-01
• Primary completion: 2007-11-01
• Completion: 2007-11-01
• First posted: 2010-01-22
• Last updated: 2024-08-06
• Results posted: 2010-02-24

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study